Sorrell Pharmaceuticals Private Limited
About Sorrell Pharmaceuticals Private Limited
Data last updated:
Sorrell Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 13 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC116536. Its GSTIN is 36AAYCS5107M1ZM (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anumalasetty Tarakanadh and Venkata Ramana Guttula.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.42 Lakh, a growth of 88% compared to the previous year. For the same year it recorded a net loss of ₹90,212 (net margin -37.3%) and EBITDA of -₹84,076 (EBITDA margin -34.8%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8 – 2 – 682/32/187, Road No 13, Hyderabad, Telangana, India – 500034
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sorrell Pharmaceuticals Private Limited
The main business activity of Sorrell Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sorrell Pharmaceuticals Private Limited FY 2022 filings available
Sorrell Pharmaceuticals Private Limited reported revenue of ₹2.42 Lakh (up 88% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Sorrell Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 104% over three years, including 88% growth in the latest year. EBITDA fell 271% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sorrell Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹84,076 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹90,212 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sorrell Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -37.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sorrell Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Practo RX Services Private Limited | ₹2.44 Lakh (FY 2025) | •••• | •••• | -95.0% | •••• | Bangalore, Karnataka, India |
| Carolene Therapeutics Private Limited | ₹2.43 Lakh (FY 2024) | •••• | •••• | -54.0% | •••• | Aurangabad, Maharashtra, India |
| DVSR Life Sciences Private Limited | ₹2.43 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Albert Pharmaceuticals Private Limited | ₹2.43 Lakh (FY 2021) | •••• | •••• | -49.0% | •••• | Gopalganj, Bihar, India |
| Shatau Life Science Private Limited | ₹2.42 Lakh (FY 2023) | •••• | •••• | -65.0% | •••• | Ahmedabad, Gujarat, India |
| Sorrell Pharmaceuticals Private Limited this company | ₹2.42 Lakh (FY 2022) | •••• | •••• | 88.0% | •••• | Hyderabad, Telangana, India |
| Calista Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2022) | •••• | •••• | 20.0% | •••• | Nayagarh, Odisha, India |
| Emblem Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Delhi, India |
| Evoluent Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2021) | •••• | •••• | -55.0% | •••• | Palace Guttahalli, Karnataka, India |
| Omish Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2023) | •••• | •••• | -93.0% | •••• | Delhi, India |
| Sanity Life-Sciences Private Limited | ₹2.4 Lakh (FY 2025) | •••• | •••• | -71.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Sorrell Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anumalasetty Tarakanadh Also directs: Sultan Health Care and Cosmetics Private Limited | Director | 14 Dec 2023 | 2 Years 9 Months | Current |
| Venkata Ramana Guttula | Additional Director | 13 Mar 2023 | 3 Years 7 Months | Current |
Ownership and Shareholding of Sorrell Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sorrell Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Sorrell Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Alakuntla Vijaya Lakshmi ceased to be Director on 17 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Sorrell Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sorrell Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sorrell Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAYCS5107M1ZM | Telangana | Active | 11 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sorrell Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sorrell Pharmaceuticals Private Limited
Sorrell Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 13 April 2017 (9+ years old) and is registered under CIN U24304TG2017PTC116536.
Sorrell Pharmaceuticals reported revenue of ₹2.42 Lakh for FY 2022 (up 88% YoY).
Sorrell Pharmaceuticals has 2 current directors:
- Anumalasetty Tarakanadh - Director
- Venkata Ramana Guttula - Additional Director
Sorrell Pharmaceuticals reported a net loss of ₹90,212 (net margin -37.3%) and EBITDA of -₹84,076 (EBITDA margin -34.8%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sorrell Pharmaceuticals is 104% over three years. In the latest year (FY 2022) revenue rose 88%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sorrell Pharmaceuticals is 36AAYCS5107M1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Sorrell Pharmaceuticals is U24304TG2017PTC116536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sorrell Pharmaceuticals was incorporated on 13 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sorrell Pharmaceuticals by revenue are Practo RX Services Private Limited, Carolene Therapeutics Private Limited, DVSR Life Sciences Private Limited, Albert Pharmaceuticals Private Limited, Shatau Life Science Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Alakuntla Vijaya Lakshmi ceased to be Director on 17 Feb 2024. Anumalasetty Tarakanadh was appointed as Director on 14 Dec 2023. Naga Ramesh Gogula ceased to be Director on 06 Nov 2023. Sorrell Pharmaceuticals has 4 board changes on record in total.
The registered office of Sorrell Pharmaceuticals is at 8 – 2 – 68232187, Road No 13, Hyderabad, Telangana, India – 500034.